Two New ALK Novel Fusion Proteins Identified in Lung Adenocarcinoma

被引：0
|
作者：
Lee, B.
Hong, M.
Lira, M.
Mao, M.
Takeuchi, K.
Han, J.
Kim, J.
Choi, Y-L
机构：
[1] Sungkyunkwan Univ, Samsung Med Ctr, Coll Med, Seoul, South Korea
[2] Pfizer Oncol, San Diego, CA USA
[3] Canc Inst Hosp, Japanese Fdn Canc Res, Pathol Project Mol Targets, Div Pathol,Canc Inst, Tokyo, Japan
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Inst Refractory Canc Res, Seoul, South Korea
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1995
引用
收藏
页码：485A / 485A
页数：1
相关论文
共 50 条
  • [1] Two New ALK Novel Fusion Proteins Identified in Lung Adenocarcinoma
    Lee, B.
    Hong, M.
    Lira, M.
    Mao, M.
    Takeuchi, K.
    Han, J.
    Kim, J.
    Choi, Y-L
    [J]. MODERN PATHOLOGY, 2014, 27 : 485A - 485A
  • [2] TMED2-ALK, a Novel ALK Fusion Gene Identified in a Patient With Lung Adenocarcinoma
    Mao, Weijun
    Chen, Ruo
    Zhang, Junling
    Zheng, Mingfeng
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (03) : E37 - E39
  • [3] PARD3-ALK: A novel ALK fusion gene identified in a patient with lung adenocarcinoma
    Yang, Liangwei
    Zhao, Weidi
    Zhu, Huangkai
    Li, Xi
    Zhao, Guofang
    [J]. LUNG CANCER, 2021, 154 : 219 - 220
  • [4] HIP1-ALK, a Novel Fusion Protein Identified in Lung Adenocarcinoma
    Hong, Mineui
    Kim, Ryong Nam
    Song, Ji-Young
    Choi, So-Jung
    Oh, Ensel
    Lira, Maruja E.
    Mao, Mao
    Takeuchi, Kengo
    Han, Joungho
    Kim, Jhingook
    Choi, Yoon-La
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (03) : 419 - 422
  • [5] A Novel Fusion of TPR and ALK in Lung Adenocarcinoma
    Choi, Yoon-La
    Lira, Maruja E.
    Hong, Mineui
    Kim, Ryong Nam
    Choi, So-Jung
    Song, Ji-Young
    Pandy, Kinnari
    Mann, Derrick L.
    Stahl, Joshua A.
    Peckham, Heather E.
    Zheng, Zongli
    Han, Joungho
    Mao, Mao
    Kim, Jhingook
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : 563 - 566
  • [6] A novel 5′ALK fusion identified by next generation sequencing and validated by IHC in a patient with lung adenocarcinoma
    He, Zhengfu
    Zhu, Xingyu
    Zeng, Qingxin
    Yu, Zhaonan
    [J]. LUNG CANCER, 2021, 158 : 164 - 165
  • [7] SMPD3-ALK: A novel ALK fusion gene in lung adenocarcinoma
    Liang, Yuepei
    Wang, Yang
    Wang, Wenjing
    Zhao, Juan
    Xu, Mian
    Zheng, Min
    [J]. CLINICAL GENETICS, 2021, 99 (03) : 488 - 489
  • [8] Next-generation Sequencing Identified a Novel WDPCP-ALK Fusion Sensitive to Crizotinib in Lung Adenocarcinoma
    He, Zhen
    Wu, Xuan
    Ma, Shuxiang
    Zhang, Cuicui
    Zhang, Zhe
    Wang, Shuai
    Yu, Sheng
    Wang, Qiming
    [J]. CLINICAL LUNG CANCER, 2019, 20 (05) : E548 - E551
  • [9] Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors
    Yang, Dafu
    Li, Dan
    Dai, Zhaoxia
    Ma, Yutong
    Ou, Qiuxiang
    Wu, Xue
    Cui, Saiqiong
    [J]. CANCER COMMUNICATIONS, 2021, 41 (02) : 183 - 186
  • [10] Targeting SLMAP-ALK-a novel gene fusion in lung adenocarcinoma
    Pagan, Carlos
    Barua, Subit
    Hsiao, Susan J.
    Mansukhani, Mahesh
    Saqi, Anjali
    Murty, Vundavalli
    Fernandes, Helen
    [J]. COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2019, 5 (03):
12345